Daily Archives: February 24, 2017

Construction Market Research by Market Segmentation,size,growth and Leading Key in-Depth Analysis Report of Hong Kong

HTF Market Intelligence released a new research report of 32 pages on title ‘Construction in Hong Kong’  with detailed analysis, forecast and strategies.

Summary

Construction in Hong Kong industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the construction market in Hong Kong

Clinical Laboratory Services Market to Reach US$241.3 bn by 2019 owing to Early Detection Capabilities of Numerous Specialized Diagnostic Tests

A new Transparency Market Research report states that the global clinical laboratory services market stood at US$162.7 bn in 2012 and is predicted to reach US$241.3 bn by 2019. It is predicted to expand at a CAGR of 5.80% from 2013 to 2019. The title of the report is “Clinical Laboratory Services Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.

Browse the full Clinical Laboratory Services Market (Clinical Chemistry, Medical Microbiology & Cytology, Human & Tumor Genetics and Other Esoteric Tests) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 report at http://www.transparencymarketresearch.com/clinical-laboratory-services-market.html

Improving General Fertility Rate Steers Sales of Pregnancy Products Worldwide, says TMR

The top three players leading the U.S. pregnancy product market collectively hold a share of 25% in the overall market, Transparency Market Research (TMR) finds. The largest share of about 10% is held by Expanscience Laboratories, Inc. Its leading brands, Mustela and Piascledine 300, are spread over 97 countries, garnering a remarkable presence and indomitable revenues. Currently, Expanscience Laboratories, Inc. has 808 patents registered around the world, which will give it a competitive advantage over others in the foreseeable future.

Intensifying Research in Drug Discovery to Increase Adoption of Genomics and Proteomics Technologies in Healthcare Facilities, reports TMR

The global genomics and proteomics reagent and analytical instruments market has seen the emergence of new regional players, many of whom have successfully expanded beyond their original markets, reports Transparency Market Research (TMR) in a new study. Due to the high level of competitive rivalry within the market, the companies operating in this field are impelled to adopt highly competitive pricing and marketing strategies. The top three market players accounted for approximately 52.4% in the global genomics and proteomics market in 2012. The leading market player is Agilent followed by Thermofisher, and Life Technologies.   

Global Molecular Cytogenetics Market to Reach US$1.9 bn by 2019 due to Rising Occurrence of Cancer Globally

A new Transparency Market Research report states that the global molecular cytogenetics market was valued at US$0.4 bn in 2012 and is expected to reach US$1.9 bn by the end of 2019, by expanding at an astounding 23.40% CAGR between 2013 and 2019. The title of the report is “Molecular Cytogenetics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

Browse the full Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 report at http://www.transparencymarketresearch.com/molecular-diagnostics-market.html

Easing of Regulatory Policies to Drive Global Demand for Companion Diagnostics, reports TMR

Due to the dominance of the top three players in the global companion diagnostics market, the nature of the market is highly oligopolistic, says Transparency Market Research in a new study. The leading companies operating in the market are focusing on protecting their patent rights to retain exclusivity. The top three companies in the companion diagnostics market are Roche Holdings followed by Qiagen N.V., and Agilent Technologies. Together they comprise approximately 80.4% of the overall global market in 2012.

Global Medical Tourism Market to Reach US$32.5 bn in 2019, Availability of Cost-effective Treatments in Emerging Nations Encourages Medical Tourism

A market study on the global tourism market, recently published by Transparency Market Research (TMR) estimates this market to rise at an exceptional CAGR of 17.90% over the period from 2013 to 2019 and reach a value US$32.5 bn by the end of the forecast period.The research report, titled “Medical Tourism Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” states that the worldwide medical tourism market attained a value of US$10.5 bn in 2012.

Browse the full Medical Tourism Market (India, Thailand, Singapore, Malaysia, Mexico, Brazil, Taiwan, Turkey, South Korea, Costa Rica, Poland, Dubai and Philippines) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 report at http://www.transparencymarketresearch.com/medical-tourism.html

Global Atrial Fibrillation Market to Touch US$14.8 bn by 2019; Graying Population and Chronic Disease Prevalence Drive Growth

Atrial fibrillation, a condition whose symptoms are irregular and/or rapid heartbeats, affected an estimated 33.5 mn individuals worldwide as of 2010. The World Health Organization (WHO) has termed the condition as a “growing global health concern”. In order to further understand how the market for global atrial fibrillation market treatments is developing, Transparency Market Research has published a report, titled ‘Atrial Fibrillation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.’ According to the estimations of TMR’s study, the market is expected to rise at a compounded annual growth rate (CAGR) of 13.4% between 2013 and 2019. The report further states that the market stood at a valuation of US$6.1 bn in 2012 and will touch US$14.8 bn by 2019.

Nonalcoholic Steatohepatitis (NASH) Therapeutics Market to Reach US$20.27 bn by 2025, Elafibranor Projected to Spur Growth

According to a new market report published by Transparency Market Research “Nonalcoholic Steatohepatitis Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2025”, the nonalcoholic steatohepatitis (NASH) therapeutics market is anticipated to expand at a CAGR of 10.7% from 2015 to 2025 to reach US$20.27 bn by 2025.

Browse the full Nonalcoholic Steatohepatitis Therapeutics Market (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2025 report at http://www.transparencymarketresearch.com/nonalcoholic-steatohepatitis-market.html

Designed by CyFocus.com
Powered by CyFocus.net